State Street’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-223,262
| Closed | -$223K | – | 4582 |
|
|
2023
Q3 | $223K | Hold |
223,262
| – | – | ﹤0.01% | 3908 |
|
|
2023
Q2 | $109K | Sell |
223,262
-1,052,725
| -83% | -$861K | ﹤0.01% | 4218 |
|
|
2023
Q1 | $1.48M | Buy |
1,275,987
+12,987
| +1% | +$23.7K | ﹤0.01% | 3426 |
|
|
2022
Q4 | $3.38M | Buy |
1,263,000
+13,235
| +1% | +$34.9K | ﹤0.01% | 3211 |
|
|
2022
Q3 | $3.57M | Buy |
1,249,765
+168,081
| +16% | +$715K | ﹤0.01% | 3221 |
|
|
2022
Q2 | $5.38M | Buy |
1,081,684
+12,055
| +1% | +$63.1K | ﹤0.01% | 3067 |
|
|
2022
Q1 | $7.61M | Buy |
1,069,629
+165,241
| +18% | +$1.37M | ﹤0.01% | 2968 |
|
|
2021
Q4 | $16.4M | Buy |
904,388
+92,077
| +11% | +$1.99M | ﹤0.01% | 2611 |
|
|
2021
Q3 | $15.9M | Buy |
812,311
+108,993
| +15% | +$4.14M | ﹤0.01% | 2621 |
|
|
2021
Q2 | $31.5M | Buy |
703,318
+468,789
| +200% | +$21.7M | ﹤0.01% | 2193 |
|
|
2021
Q1 | $11.8M | Buy |
234,529
+120,968
| +107% | +$8.25M | ﹤0.01% | 2663 |
|
|
2020
Q4 | $10.2M | Buy |
113,561
+61,184
| +117% | +$5.15M | ﹤0.01% | 2622 |
|
|
2020
Q3 | $4M | Buy |
+52,377
| New | +$3.33M | ﹤0.01% | 2890 |
|
State Street's CELL Position: Q4 2023 in Review
State Street sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 223,262 shares — an estimated $223K sold.
State Street first reported a position in CELL in Q3 2020 and held it in 13 quarters. The position peaked at $31.5M in Q2 2021. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.
- State Street reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- State Street sold 223,262 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $223K.
- State Street first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 13 quarters.
- State Street's PhenomeX Inc. Common Stock position peaked at $31.5M in Q2 2021.
- 0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.
Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.